CFG
GILD icon

Clayton Financial Group’s Gilead Sciences GILD Stock Holding History

Clayton Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-183
Closed -$25.5K – 267
2026
Q1 		$25.5K Hold
183
– – 0.01% 174
2025
Q4 		$22.5K Buy
+183
New +$22.2K 0.01% 179

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Clayton Financial Group's GILD Position: Q2 2026 in Review

Clayton Financial Group sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 183 shares — an estimated $25.5K sold.

Clayton Financial Group first reported a position in GILD in Q4 2025 and held it in 2 quarters. The position peaked at $25.5K in Q1 2026. 965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Clayton Financial Group reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 183 Gilead Sciences shares in Q2 2026, an estimated $25.5K.
  • Clayton Financial Group first reported a position in Gilead Sciences in Q4 2025 and held it in 2 quarters.
  • Clayton Financial Group's Gilead Sciences position peaked at $25.5K in Q1 2026.
  • 965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.